Related Experiment Video
Updated: Apr 20, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Telehealth and Hybrid Service Use for Major Depression and Substance Use Disorders Among U.S. Adults, 2022-2023
Wenhua Lu1, Yifan Liu2, Anderson Sungmin Yoon3
1Department of Community Health and Social Medicine, School of Medicine, The City University of New York, New York, New York.
Introduction:
This study examined patterns of telehealth and hybrid service use (telehealth combined with outpatient or inpatient care) for major depressive episodes and substance use disorders among U.S. adults.
Methods:
Pooled data from the 2022 and 2023 National Survey on Drug Use and Health (N=92,233) were analyzed to examine trends and patterns in overall telehealth use and hybrid service use among adults with past-year major depressive episodes and those with past-year substance use disorders. Bivariate analyses and survey-weighted multivariable logistic regression were conducted between December 2024 and May 2025.
Results:
Among adults with past-year major depressive episodes, telehealth use remained stable at around 44% from 2022 to 2023, whereas outpatient care remained the most common treatment modality and increased from 46.1% to 50.0% (OR=1.16, p<0.05). Among adults with past-year substance use disorders, telehealth use increased nonsignificantly from 5.4% in 2022 to 6.2% in 2023. For major depressive episodes, telehealth use was higher among females than among males (AOR=1.41, p<0.001) and among those with Medicaid (AOR=1.90, p<0.001) or private insurance (AOR=1.79, p<0.001) than among uninsured adults. Adults with major depressive episode-related severe impairment were more likely to use telehealth overall (AOR=1.55, p<0.001) and hybrid care. For substance use disorders, adults living in small metropolitan areas had lower telehealth use than those in large metropolitan areas (AOR=0.77, p<0.05). Telehealth use was also higher among those with moderate (AOR=2.72, p<0.001) or severe (AOR=10.04, p<0.001) substance use disorders than those with mild substance use disorders.
Conclusions:
Telehealth and hybrid service use for major depressive episodes and substance use disorders remained largely stable in the postpandemic period. When integrated with in-person care, telehealth can help expand access to mental health and substance use treatment among U.S. adults.
More Related Videos
Related Concept Videos
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Drug Therapy
Antianxiety Medications
Self-Help Support Groups
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Antidepressant Drugs: MAOIs and Other Agents
Depression: Overview

